Effects of doxorubicin and gemcitabine on the induction of apoptosis in breast cancer cells

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2719-2725

Spandidos Publications

Access to resources Recommend Favorite

Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer

By Rha Sun  

Breast Cancer Research and Treatment, Vol. 90, Iss. 3, 2005-04 ,pp. : 215-221

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine: In Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer

By Moen Marit D.   Wellington Keri  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 327-333

Adis International

Access to resources Recommend Favorite

Can patients with metastatic breast cancer be cured after introduction of newer and more effective agents?

By Ohno Shinji  

Breast Cancer, Vol. 19, Iss. 3, 2012-07 ,pp. : 212-217

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

By Ulrich-Pur Herbert   Kornek Gabriela   Haider Karin   Kwasny Werner   Payrits Thomas   Dworan Nina   Vormittag Laurenz   Depisch Dieter   Lang Fritz   Scheithauer Werner  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite